Literature DB >> 3530432

Metastatic interstitial pneumonitis after autologous bone marrow transplantation. A consequence of reinjection of malignant cells?

P Glorieux, E Bouffet, I Philip, P Biron, L Holzapfel, D Floret, R Bouvier, D Vitrey, R Pinkerton, M Brunat-Mentigny.   

Abstract

Two cases of fatal interstitial pneumonitis developing after an autologous bone marrow transplantation are described. In both cases the autopsy revealed diffuse malignant pulmonary involvement. The first case involved a 4-year-old boy who had a Burkitt's lymphoma; the second case involved a 4-year-old girl with a neuroblastoma. The authors postulate that in these cases, the clinical picture may have been related to reinfusion of malignant cells.

Entities:  

Mesh：

Year:  1986        PMID： 3530432     DOI： 10.1002/1097-0142(19861101)58:9<2136::aid-cncr2820580929>3.0.co;2-j

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  5 in total

1.  Introduction to bone marrow transplant symposium held at the Albert Einstein Cancer Center at Bronx, NY, USA, March 23 to 25, 1994.

Authors:  R Gucalp; J Sparano; J P Dutcher; P H Wiernik
Journal:  Med Oncol       Date:  1994       Impact factor: 3.064

2.  Lack of evidence of osteo-medullary metastases at diagnosis in patients with high grade gliomas.

Authors:  D Frappaz; A Jouvet; G S Pierre; F Giammarile; J Guyotat; R Deruty; E Jouanneau; D Ranchère-Vince
Journal:  J Neurooncol       Date:  2001-05       Impact factor: 4.130

3.  Model study detecting breast cancer cells in peripheral blood mononuclear cells at frequencies as low as 10(-7).

Authors:  H J Gross; B Verwer; D Houck; R A Hoffman; D Recktenwald
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

4.  The LMCE5 unselected cohort of 25 children consecutively diagnosed with untreated stage 4 neuroblastoma over 1 year at diagnosis.

Authors:  D Frappaz; D Perol; J Michon; C Berger; C Coze; J L Bernard; J M Zucker; T Philip
Journal:  Br J Cancer       Date:  2002-11-18       Impact factor: 7.640

5.  Effective removal of SCLC cells from human bone marrow. Use of four monoclonal antibodies and immunomagnetic beads.

Authors:  A T Myklebust; A Pharo; O Fodstad
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.